Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus. (15th August 2019)

• Record Type: Journal Article
• Authors: Trevillyan, Janine M; Moser, Carlee; Currier, Judith S; Sallam, Tamer
• Is Part Of: Clinical infectious diseases. Volume 70:Number 8(2020)
• Page Start: 1764
• Page End: 1767
• Publication Date: 2019-08-15
• Subjects: HIV -- cardiovascular disease -- acute myocardial infarction -- inflammation -- immune activation; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciz765
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV.